普洛药业：获得药品注册证书

Core Viewpoint - Pro Pharmaceutical Co., Ltd. announced that its subsidiary, Zhejiang Pro Kangyu Pharmaceutical Co., Ltd., has received a drug registration certificate for Cefdinir capsules from the National Medical Products Administration [2] Group 1 - The announcement was made on the evening of November 20 [2] - The drug registration certificate is a significant regulatory milestone for the company [2] - Cefdinir is an antibiotic used to treat various bacterial infections, indicating potential market opportunities for the company [2]